Plante Moran Financial Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.4K | Buy |
642
+6
| +0.9% | +$536 | ﹤0.01% | 306 |
|
|
2026
Q1 | $45.7K | Buy |
636
+1
| +0.2% | +$77 | ﹤0.01% | 327 |
|
|
2025
Q4 | $50.4K | Sell |
635
-27
| -4% | -$2.13K | ﹤0.01% | 325 |
|
|
2025
Q3 | $49.9K | Buy |
662
+27
| +4% | +$1.85K | ﹤0.01% | 336 |
|
|
2025
Q2 | $43.8K | Hold |
635
| – | – | ﹤0.01% | 359 |
|
|
2025
Q1 | $43K | Sell |
635
-1,247
| -66% | -$74.6K | ﹤0.01% | 367 |
|
|
2024
Q4 | $84.5K | Sell |
1,882
-1,010
| -35% | -$56.7K | 0.01% | 279 |
|
|
2024
Q3 | $182K | Sell |
2,892
-886
| -23% | -$51.7K | 0.02% | 191 |
|
|
2024
Q2 | $223K | Buy |
3,778
+155
| +4% | +$9.7K | 0.02% | 162 |
|
|
2024
Q1 | $289K | Buy |
3,623
+999
| +38% | +$76.3K | 0.03% | 130 |
|
|
2023
Q4 | $207K | Buy |
2,624
+208
| +9% | +$14.8K | 0.02% | 163 |
|
|
2023
Q3 | $169K | Sell |
2,416
-216
| -8% | -$15.3K | 0.02% | 164 |
|
|
2023
Q2 | $182K | Buy |
2,632
+723
| +38% | +$51.4K | 0.02% | 167 |
|
|
2023
Q1 | $142K | Sell |
1,909
-1,820
| -49% | -$153K | 0.02% | 184 |
|
|
2022
Q4 | $347K | Sell |
3,729
-97
| -3% | -$9.36K | 0.05% | 102 |
|
|
2022
Q3 | $365K | Sell |
3,826
-12
| -0.3% | -$1.19K | 0.06% | 94 |
|
|
2022
Q2 | $356K | Buy |
3,838
+112
| +3% | +$10.9K | 0.06% | 99 |
|
|
2022
Q1 | $377K | Sell |
3,726
-199
| -5% | -$20.9K | 0.07% | 106 |
|
|
2021
Q4 | $405K | Sell |
3,925
-197
| -5% | -$18.2K | 0.07% | 106 |
|
|
2021
Q3 | $350K | Buy |
4,122
+590
| +17% | +$49.4K | 0.08% | 128 |
|
|
2021
Q2 | $295K | Sell |
3,532
-1,999
| -36% | -$164K | 0.07% | 133 |
|
|
2021
Q1 | $416K | Sell |
5,531
-2,327
| -30% | -$170K | 0.11% | 91 |
|
|
2020
Q4 | $537K | Buy |
7,858
+3,138
| +66% | +$204K | 0.17% | 74 |
|
|
2020
Q3 | $276K | Buy |
4,720
+100
| +2% | +$6.22K | 0.1% | 116 |
|
|
2020
Q2 | $300K | Sell |
4,620
-595
| -11% | -$37.5K | 0.12% | 98 |
|
|
2020
Q1 | $309K | Buy |
5,215
+512
| +11% | +$34.2K | 0.14% | 89 |
|
|
2019
Q4 | $349K | Buy |
4,703
+587
| +14% | +$41.2K | 0.12% | 104 |
|
|
2019
Q3 | $260K | Sell |
4,116
-755
| -15% | -$44.7K | 0.08% | 134 |
|
|
2019
Q2 | $265K | Sell |
4,871
-342
| -7% | -$18.4K | 0.08% | 122 |
|
|
2019
Q1 | $281K | Sell |
5,213
-186
| -3% | -$11.5K | 0.09% | 118 |
|
|
2018
Q4 | $354K | Buy |
5,399
+87
| +2% | +$6.49K | 0.12% | 96 |
|
|
2018
Q3 | $418K | Sell |
5,312
-343
| -6% | -$24.5K | 0.14% | 87 |
|
|
2018
Q2 | $364K | Sell |
5,655
-204
| -3% | -$13.4K | 0.18% | 93 |
|
|
2018
Q1 | $364K | Sell |
5,859
-30
| -0.5% | -$2.15K | 0.2% | 92 |
|
|
2017
Q4 | $427K | Buy |
5,889
+454
| +8% | +$33K | 0.24% | 78 |
|
|
2017
Q3 | $442K | Sell |
5,435
-552
| -9% | -$43.7K | 0.26% | 73 |
|
|
2017
Q2 | $482K | Sell |
5,987
-114
| -2% | -$9K | 0.3% | 70 |
|
|
2017
Q1 | $479K | Sell |
6,101
-994
| -14% | -$79.4K | 0.29% | 77 |
|
|
2016
Q4 | $560K | Buy |
7,095
+536
| +8% | +$43.4K | 0.35% | 62 |
|
|
2016
Q3 | $584K | Buy |
6,559
+425
| +7% | +$40.1K | 0.39% | 54 |
|
|
2016
Q2 | $587K | Buy |
6,134
+433
| +8% | +$43.2K | 0.43% | 48 |
|
|
2016
Q1 | $591K | Sell |
5,701
-6
| -0.1% | -$583 | 0.46% | 48 |
|
|
2015
Q4 | $558K | Buy |
5,707
+530
| +10% | +$51.9K | 0.42% | 56 |
|
|
2015
Q3 | $499K | Buy |
5,177
+130
| +3% | +$13.7K | 0.39% | 58 |
|
|
2015
Q2 | $529K | Hold |
5,047
| – | – | 0.38% | 56 |
|
|
2015
Q1 | $521K | Sell |
5,047
-170
| -3% | -$17.2K | 0.36% | 63 |
|
|
2014
Q4 | $502K | Buy |
5,217
+1,526
| +41% | +$134K | 0.37% | 57 |
|
|
2014
Q3 | $294K | Buy |
3,691
+258
| +8% | +$20.3K | 0.26% | 70 |
|
|
2014
Q2 | $259K | Buy |
3,433
+657
| +24% | +$49.7K | 0.23% | 72 |
|
|
2014
Q1 | $208K | Sell |
2,776
-2,214
| -44% | -$156K | 0.23% | 70 |
|
|
2013
Q4 | $357K | Buy |
4,990
+1,239
| +33% | +$79.6K | 0.2% | 63 |
|
|
2013
Q3 | $213K | Buy |
3,751
+999
| +36% | +$59.5K | 0.13% | 69 |
|
|
2013
Q2 | $157K | Buy |
+2,752
| New | +$159K | 0.12% | 78 |
|
Other funds holding CVS
Plante Moran Financial Advisors's CVS Position: Q2 2026 in Review
Plante Moran Financial Advisors increased its CVS Health (CVS) stake by 0.94% in Q2 2026, buying an estimated $536 and bringing the position to 642 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #306.
Plante Moran Financial Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $591K in Q1 2016. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Plante Moran Financial Advisors held 642 shares of CVS Health worth $66.4K as of Q2 2026.
- Plante Moran Financial Advisors bought 6 CVS Health shares in Q2 2026, an estimated $536.
- CVS Health made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #306 holding.
- Plante Moran Financial Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Plante Moran Financial Advisors's CVS Health position peaked at $591K in Q1 2016.
- 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.